Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoyuki Nishiya

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|May 25, 2006
[Inside-out integrin activation links micro- to macro-dynamics]Naoyuki Nishiya
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 4, 2017
Screening for Chemical Suppressors of the Wnt/β-catenin Signaling PathwayNaoyuki Nishiya
Seikagaku. the Journal of Japanese Biochemical Society|May 24, 2006
[Alpha4 integrins control front-rear polarity during cell migration]Naoyuki Nishiya
The Journal of Antibiotics|August 12, 2021
Domestication of chemicals attacking metazoan embryogenesis: identification of safe natural products modifying developmental signaling pathways in humanNaoyuki Nishiya, Honami Yonezawa
Journal of Biochemistry|August 3, 2002
Hic-5 interacts with GIT1 with a different binding mode from paxillinNaoyuki Nishiya, Takeshi Shirai, Wataru Suzuki, et al.
Biochemical and Biophysical Research Communications|May 19, 2011
Identification of LY83583 as a specific inhibitor of Candida albicans MPS1 protein kinaseKayoko Tsuda, Naoyuki Nishiya, Takashi Umeyama, et al.
Pharmaceuticals (Basel, Switzerland)|November 10, 2019
Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor SignalingNaoyuki Nishiya, Moeka Murai, Ayumi Hosoda, et al.
Nature Cell Biology|March 29, 2005
An alpha4 integrin-paxillin-Arf-GAP complex restricts Rac activation to the leading edge of migrating cellsNaoyuki Nishiya, William B Kiosses, Jaewon Han, et al.
World Journal of Biological Chemistry|December 3, 2015
JAK3 inhibitor VI is a mutant specific inhibitor for epidermal growth factor receptor with the gatekeeper mutation T790MNaoyuki Nishiya, Yasumitsu Sakamoto, Yusuke Oku, et al.
Anticancer Research|June 1, 2018
Sensitisation of Cancer Cells to MLN8237, an Aurora-A Inhibitor, by YAP/TAZ InactivationYusuke Oku, Naoyuki Nishiya, Shuhei Sugiyama, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|May 25, 2006
[Inside-out integrin activation links micro- to macro-dynamics]Naoyuki Nishiya
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 4, 2017
Screening for Chemical Suppressors of the Wnt/β-catenin Signaling PathwayNaoyuki Nishiya
Seikagaku. the Journal of Japanese Biochemical Society|May 24, 2006
[Alpha4 integrins control front-rear polarity during cell migration]Naoyuki Nishiya
The Journal of Antibiotics|August 12, 2021
Domestication of chemicals attacking metazoan embryogenesis: identification of safe natural products modifying developmental signaling pathways in humanNaoyuki Nishiya, Honami Yonezawa
Journal of Biochemistry|August 3, 2002
Hic-5 interacts with GIT1 with a different binding mode from paxillinNaoyuki Nishiya, Takeshi Shirai, Wataru Suzuki, et al.
Biochemical and Biophysical Research Communications|May 19, 2011
Identification of LY83583 as a specific inhibitor of Candida albicans MPS1 protein kinaseKayoko Tsuda, Naoyuki Nishiya, Takashi Umeyama, et al.
Pharmaceuticals (Basel, Switzerland)|November 10, 2019
Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor SignalingNaoyuki Nishiya, Moeka Murai, Ayumi Hosoda, et al.
Nature Cell Biology|March 29, 2005
An alpha4 integrin-paxillin-Arf-GAP complex restricts Rac activation to the leading edge of migrating cellsNaoyuki Nishiya, William B Kiosses, Jaewon Han, et al.
World Journal of Biological Chemistry|December 3, 2015
JAK3 inhibitor VI is a mutant specific inhibitor for epidermal growth factor receptor with the gatekeeper mutation T790MNaoyuki Nishiya, Yasumitsu Sakamoto, Yusuke Oku, et al.
Anticancer Research|June 1, 2018
Sensitisation of Cancer Cells to MLN8237, an Aurora-A Inhibitor, by YAP/TAZ InactivationYusuke Oku, Naoyuki Nishiya, Shuhei Sugiyama, et al.
Pageof 4